Abstract
Subcutaneous plasma derived C1 inhibitor for long-term prophylaxis during pregnancy and breastfeeding in a patient with Factor XII hereditary angioedema.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have